Please take a few minutes of your time to complete
the following questionnaire (average time of completion: 3-5 minutes).
A team from Cambridge University is developing next generation, off-the-shelf bioengineered vascular grafts for dialysis treatment. While current grafts have enabled progress in the field of dialysis, improvements are still necessary to reduce further the risk of complications such as infection and blood clotting. The Cambridge team aims to tackle these shortcomings by generating grafts made of densified collagen hydrogel, a cutting-edge biological material in the field of tissue engineering. Similar in makeup to natural blood vessels, the Cambridge graft interacts well with patient’s own tissues and immune system, leading to good healing, low infection rates and low risk of blood clotting. Furthermore, the grafts are fully customisable to address the patient’s needs. The Cambridge team is seeking to demonstrate reductions in surgical complications and therefore improve clinical outcomes for patients.